EP642: Zanubrutinib in previously treated B-cell malignancies intolerant to ibrutinib/acalabrutinib

 ABSTRACT   06/2021

Rating

Rate this resource

Nice to see you!

For newest details on our EHA materials in a personal video meeting, please click here!
Service